Biktarvy, formally known as bictegravir sulfate, includes a potent single-tablet regimen for treating HIV infection. This drug unites three crucial antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the HIV's ability to copy within the body, remarkably decreasing the viral load. For many individuals,